Maya Koronyo‐Hamaoui

The paper identifies sex-specific molecular and pathological differences in the retina-brain axis of Alzheimer's disease, linking estrogen receptor imbalance to female vulnerability.

The paper identifies UCHL1 dysregulation and synaptic loss in the retina as markers of Alzheimer's disease severity using integrated multi-omics analysis.

The paper identifies Chlamydia pneumoniae infection and NLRP3 inflammasome activation in Alzheimer's disease retinas, linking them to disease progression and cognitive impairment.

This study shows that pathological tau isoforms in retinal ganglion cells (RGCs) are linked to RGC degeneration in Alzheimer's disease, with significant correlations between tau levels and disease severity.

This study shows that inhibiting H3K9me3 with ETP69 reduces AD pathology and improves cognition by modulating neuroinflammation and inducing Vgf.

This study quantifies retinal tau isoforms in early and advanced AD and links them to brain pathology and cognitive status.

The paper quantifies retinal perivascular amyloid plaque distribution in relation to cognitive performance, finding higher peri-arteriolar amyloid burden and correlations with cognitive decline.